| 摘要 |
<p>The invention concerns the use of the neurotrophic factor derived from glyal cells (GNDF), or a substance of the family comprising said factor, as active protective agent for treating retinal degeneration, more particularly pigmentary retinopathy (RP) in human beings.</p> |
